前十大流通股东累计持有： 29910.53万股，累计占流通股比： 31.32%，较上期变化： -367.81万股。 一、主要会计数据和财务指标 | 报告期指标 | 2024年年报 | 2023年年报 | 本年比上年增减(%) | 2022年年报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | -0.0106 | -0.0876 | 87.9 | -0.0930 | | 每股净资产（元） | 1.43 | 1.44 | -0.69 | 0.78 | | 每股公积金(元) | 0.72 | 0.74 | -2.7 | 0.04 | | 每股未分配利润(元) | -0.18 | -0.17 | -5.88 | -0.09 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 3.57 | 3.3 | 8.18 | 3.11 | | 净利润(亿元) | -0.1 | -0.8 | 87.5 | -0.84 | | 净资产收益率(%) | -0.73 | -10.42 | 92.99 | -11.29 | 数据四舍五入，查看更多财务数 ...

一、主要会计数据和财务指标 10派3.0元(含税) | 报告期指标 | 2024年年报 | 2023年年报 | 本年比上年增减(%) | 2022年年报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 1.7600 | 2.0600 | -14.56 | 1.2100 | | 每股净资产（元） | 8.65 | 6.57 | 31.66 | 5.75 | | 每股公积金(元) | 3.72 | 1.64 | 126.83 | 2.56 | | 每股未分配利润(元) | 3.81 | 3.81 | 0 | 2.11 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 41.35 | 37.32 | 10.8 | 31.99 | | 净利润(亿元) | 7.26 | 8.12 | -10.59 | 4.82 | | 净资产收益率(%) | 24.06 | 29.19 | -17.57 | 22.94 | | 占总股本比例 | 名称 | 持有数量(万股) | | 增减情况(万 | | --- | --- | --- | --- ...

一、主要会计数据和财务指标 前十大流通股东累计持有： 31166.6万股，累计占流通股比： 59.87%，较上期变化： -452.98万股。 | 名称 | 持有数量(万股) | 占总股本比例 | 增减情况(万 | | --- | --- | --- | --- | | | | (%) | 股) | | 恒融投资集团有限公司 | 24167.00 | 46.43 | 不变 | | 王淑琴 | 5669.95 | 10.89 | 不变 | | 江浩然 | 344.58 | 0.66 | 不变 | | 华宝中证金融科技主题ETF | 201.04 | 0.39 | 新进 | | 梁留生 | 179.15 | 0.34 | 新进 | | 周哲 | 170.87 | 0.33 | 新进 | | 张云峰 | 139.43 | 0.27 | 新进 | | 顾春梅 | 100.05 | 0.19 | 新进 | | 沈芸 | 100.00 | 0.19 | 新进 | | 张学连 | 94.53 | 0.18 | 新进 | | 较上个报告期退出前十大股东有 | | | | | 罗宗曼 | 398.66 | 0.77 | 退出 | ...

年报披露季接近尾声，投资者如果想通过年报寻找上市公司2025年新的投资机会，可以重点关注以下几 个方向。一是主营业务大幅扩张，二是重金投资朝阳行业，三是消费领域受到投资者青睐。此外，经营 性现金流，流动比率和速动比率也是很重要的指标。 在年报中，有几个方向尤为值得投资者重点关注，它们或许能预示上市公司2025年的业绩变化趋势。 首先，主营业务的大幅扩张是上市公司成长性的重要体现。一个公司能够持续扩大其主营业务规模，往 往意味着其在市场中具有较强的竞争力和拓展能力。这种扩张可能源于市场份额的提升、新产品的推出 或是业务范围的拓展。投资者应密切关注那些主营业务收入显著增长的公司，它们很可能是未来行业中 的佼佼者。这些公司的成长故事往往伴随着股价的上涨，为投资者带来丰厚的投资回报。 其次，重金投资朝阳行业的公司也值得关注。朝阳行业代表着未来的发展方向和趋势，如新能源、生物 科技、人工智能等。上市公司若能在这些领域提前布局，并投入大量资金进行研发和市场拓展，那么它 们有望在未来行业中占据领先地位。投资者应关注那些对朝阳行业有深刻理解和前瞻性布局的公司，它 们的投资决策可能预示着未来的行业风口。 北京商报评论员 周科竞 ...

本次公司不分配不转赠。 | 名称 | 持有数量(万股) | 占总股本比例(%) | 增减情况(万股) | | --- | --- | --- | --- | | 集晶(香港)有限公司 | 6891.00 | 31.74 | 不变 | | 李新岗 | 622.12 | 2.87 | 不变 | | 吴晓虹 | 269.75 | 1.24 | 不变 | | 霍鹏冲 | 256.30 | 1.18 | 不变 | | 香港中央结算有限公司 | 246.23 | 1.13 | 101.84 | | 肖玲 | 225.90 | 1.04 | -0.11 | | 康云 | 178.50 | 0.82 | 不变 | | 张亚飞 | 165.56 | 0.76 | 不变 | | 吴玉胜 | 144.15 | 0.66 | -4.10 | | 刁云景 | 144.00 | 0.66 | 不变 | 三、分红送配方案情况 一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股 ...

Financial Performance - The company's basic earnings per share decreased by 25% from 0.1600 yuan in 2023 to 0.1200 yuan in 2024 [1] - Net profit fell by 25.59%, from 2.11 billion yuan in 2023 to 1.57 billion yuan in 2024 [1] - Operating revenue decreased by 3.42%, from 1.17 billion yuan in 2023 to 1.13 billion yuan in 2024 [1] - Return on equity dropped by 30.02%, from 4.63% in 2023 to 3.24% in 2024 [1] - The company's net asset per share increased by 7.95%, from 3.52 yuan in 2023 to 3.8 yuan in 2024 [1] - Undistributed profits per share rose by 3.9%, from 1.54 yuan in 2023 to 1.60 yuan in 2024 [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 43,148.35 million shares, accounting for 32.47% of the circulating shares, a decrease of 1,632.09 million shares from the previous period [1] - Chongqing International Trust Co., Ltd. remains the largest shareholder with 19,880.02 million shares, unchanged from the previous report [2] - New entrants among the top shareholders include Wang Jieqing with 851.16 million shares and Zhang Suqiong with 624.45 million shares [2] - Notable exits from the top ten shareholders include Zhang Xingjin and Liang Guangpei, who have withdrawn with 2,263.37 million shares and 812.14 million shares, respectively [2] Dividend Distribution - The company announced a dividend distribution plan of 0.360 yuan per share (including tax) [2]

Financial Performance - The basic earnings per share for Q1 2025 is 0.0306 yuan, a decrease of 1.92% compared to Q1 2024, which was 0.0312 yuan [1] - The net asset per share has dropped to 3.53 yuan, reflecting a significant decline of 22.59% from 4.56 yuan in Q1 2024 [1] - The retained earnings per share decreased by 22.64%, from 2.12 yuan in Q1 2024 to 1.64 yuan in Q1 2025 [1] - The operating revenue for Q1 2025 is 1.02 billion yuan, down 3.77% from 1.06 billion yuan in Q1 2024 [1] - The net profit remains unchanged at 0.05 billion yuan for both Q1 2025 and Q1 2024 [1] - The return on equity is 0.87%, slightly down from 0.89% in Q1 2024 [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 94.53 million shares, accounting for 58.53% of the circulating shares, with a decrease of 418,300 shares from the previous period [1] - The largest shareholder, Xin Jun, holds 48.56 million shares, representing 30.07% of the total share capital, with no change [2] - New entrant Gong Wenfeng holds 3.11% of the shares, while Ji Junsheng has reduced his holdings by 40.13% [2] Dividend Policy - The company has announced that there will be no distribution or transfer of dividends this time [2]

一、主要会计数据和财务指标 三、分红送配方案情况 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | -0.0080 | -0.0118 | 32.2 | 0.0034 | | 每股净资产（元） | 2.39 | 2.55 | -6.27 | 2.85 | | 每股公积金(元) | 1.23 | 1.21 | 1.65 | 1.17 | | 每股未分配利润(元) | 0.17 | 0.37 | -54.05 | 0.66 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 3.37 | 3.21 | 4.98 | 1.06 | | 净利润(亿元) | -0.02 | -0.03 | 33.33 | 0.01 | | 净资产收益率(%) | -0.33 | -0.46 | 28.26 | 0.12 | 前十大流通股东累计持有： 5775.19万股，累计占流通股比： 28.02%，较上期变化： -515.76万股。 | 名称 ...

前十大流通股东累计持有： 5830.32万股，累计占流通股比： 42.65%，较上期变化： -104.53万股。 | 名称 | 持有数量(万股) | 占总股本比 | 增减情况 | | --- | --- | --- | --- | | | | 例(%) | (万股) | | 福建奥华集团有限公司 | 2706.87 | 19.80 | -800.00 | | 福建平潭奥泰科技投资中心(有限合伙) | 802.50 | 5.87 | 不变 | | 漳州战新创业投资基金管理有限公司-漳州圆山大健康产业 | | | | | 投资基金合伙企业(有限合伙) | 800.00 | 5.85 | 新进 | | 叶理青 | 338.42 | 2.48 | 不变 | | 中信建投（601066）医改A | 230.00 | 1.68 | 不变 | | 李国平 | 225.02 | 1.65 | 不变 | | 蔡云霞 | 216.05 | 1.58 | 1.00 | | 李国栋 | 187.50 | 1.37 | 不变 | | 黄彩艳 | 178.80 | 1.31 | 不变 | | 中欧医疗健康混合A | 145.16 | 1 ...

Financial Performance - The company reported a basic earnings per share of -0.0068 yuan for Q1 2025, a decrease of 244.68% compared to Q1 2024, which had earnings of 0.0047 yuan [1] - The net profit for Q1 2025 was -0.02 billion yuan, representing a 300% decline from the net profit of 0.01 billion yuan in Q1 2024 [1] - The operating revenue for Q1 2025 was 0.67 billion yuan, down 11.84% from 0.76 billion yuan in Q1 2024 [1] - The return on equity (ROE) for Q1 2025 was -0.23%, a significant drop from 0.16% in Q1 2024 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 83.73 million shares, accounting for 41.78% of the circulating shares, which is a decrease of 13.89 million shares from the previous period [1] - Major shareholders include Mu Yufang with 22.58 million shares (11.26%), Xu Jin with 18.35 million shares (9.15%), and Ningbo Ningju Asset Management with 13.61 million shares (6.79%) [2] - Xu Bin reduced his holdings by 13.76 million shares, while a new entry, Haoze Zhiyuan, holds 4.29 million shares (2.14%) [2] Dividend Policy - The company has announced that it will not distribute dividends or bonus shares this time [2]